Theralase Technologies Inc. (TLT.V)


TSXV - TSXV Delayed Price. Currency in CAD
0.38-0.01 (-3.85%)
At close: 3:53 PM EDT
People also watch:
ZMS.VPHM.VSBM.VKEK.VCXV.V
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.38
Prev Close0.39
Bid0.37 x
Ask0.39 x
Day's Range0.38 - 0.38
52wk Range0.26 - 0.45
1y Target EstN/A
Market Cap40.14M
P/E Ratio (ttm)-7.50
Beta-1.57
Volume145,583
Avg Vol (3m)129,651
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Accesswire11 hours ago

    Theralase Increases Revenue 32% in 2H2016 Financials

    TORONTO, ON / ACCESSWIRE / August 29, 2016 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on the commercialization ...

  • Accesswirelast month

    Theralase Files ITA Application to Health Canada

    TORONTO, ON / ACCESSWIRE / July 29, 2016 / Theralase Technologies Inc. (" Theralase® " or the " Company ") ( TSXV: TLT ) ( OTC: TLTFF ), a leading biotech company focused on the commercialization ...

  • Accesswire2 months ago

    Theralase to be Featured on CEO Clips

    TORONTO, ON / ACCESSWIRE / June 30, 2016 / Theralase Technologies Inc. (" Theralase® " or the " Company ") ( TSXV: TLT ) ( OTC: TLTFF ), a leading biotech company focused on the commercialization ...